Vee Medi Biotech India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-06-2024
- Paid Up Capital ₹ 0.10 M
as on 15-06-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.50 M
as on 15-06-2024
- Revenue -22.58%
(FY 2023)
- Profit -32.70%
(FY 2023)
- Ebitda -33.89%
(FY 2023)
- Net Worth 21.27%
(FY 2023)
- Total Assets 14.22%
(FY 2023)
About Vee Medi Biotech India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.50 M.
Velu Gunasekaran, Gandhimathi, and Velu Karuppasamy serve as directors at the Company.
- CIN/LLPIN
U51909TN2016PTC110881
- Company No.
110881
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vee Medi Biotech India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Velu Gunasekaran  | Director | 14-Jun-2016 | Current |
| Gandhimathi | Director | 14-Jun-2016 | Current |
| Velu Karuppasamy | Director | 03-Aug-2020 | Current |
Financial Performance and Corporate Structure Insights of Vee Medi Biotech India.
Vee Medi Biotech India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 22.58% decrease. The company also saw a substantial fall in profitability, with a 32.7% decrease in profit. The company's net worth Soared by an impressive increase of 21.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vee Medi Biotech India?
In 2023, Vee Medi Biotech India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Mar 2018 | ₹5.50 M | Open |
How Many Employees Work at Vee Medi Biotech India?
Vee Medi Biotech India has a workforce of 11 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vee Medi Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vee Medi Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
